Interleukin-13 receptor alpha2 is a novel therapeutic target for human adrenocortical carcinoma

Interleukin 13 Mediates Signal Transduction through Interleukin 13 Receptor  2 in Pancreatic Ductal Adenocarcinoma: Role of IL-13 Pseudomonas Exotoxin in Pancreatic Cancer Therapy

(2010) T. Shimamura et al.   CLINICAL CANCER RESEARCH

A Novel Role of Interleukin-13 Receptor  2 in Pancreatic Cancer Invasion and Metastasis

(2009) T. Fujisawa et al.   CANCER RESEARCH

Gene-expression profiling of adrenocortical carcinoma

(2009) Insoo Suh et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Identification of Biomarkers of Adrenocortical Carcinoma Using Genomewide Gene Expression Profiling

(2008) Gustavo G. Fernandez-Ranvier   ARCHIVES OF SURGERY

Adrenocortical carcinoma in the United States

(2008) Karl Y. Bilimoria et al.   CANCER

IL-13 cytotoxin has potent antitumor activity and synergizes with paclitaxel in a mouse model of oral squamous cell carcinoma

(2008) Mitomu Kioi et al.   INTERNATIONAL JOURNAL OF CANCER

Targeting IL-13Rα2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxin

(2008) Mitomu Kioi et al.   MOLECULAR CANCER THERAPEUTICS